Importance of perioperative management for emergency carotid artery stenting within 24h after intravenous thrombolysis for acute ischemic stroke: Case report  by Inoue, Akihiro et al.
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INTRODUCTION:  We  report  a patient  treated  successfully  via  endovascular  surgery  within  24  h after  intra-
venous  thrombolysis  using  recombinant  tissue  plasminogen  activator  for acute  cervical  internal  carotid
artery  occlusion.
PRESENTATION  OF  CASE:  A 68-year-old  man  was  admitted  to our  hospital.  Neurological  examination
revealed  severe  left-sided  motor  weakness.  Magnetic  resonance  imaging  showed  no cerebral  infarction,
but magnetic  resonance  angiography  revealed  complete  occlusion  of  the  right  internal  carotid  artery.
Systemic  intravenous  injection  of recombinant  tissue  plasminogen  activator  was  performed  within  4 h
after the onset.  But,  magnetic  resonance  angiography  still  revealed  complete  occlusion.  Revasculariza-
tion  of the  right  cervical  internal  carotid  artery  was  performed  via  endovascular  surgery.  The  occluded
artery  was  successfully  recanalized  using  the  Penumbra  System® and  stent  placement  at  the  origin  of
the  internal  carotid  artery.  Immediately  after surgery,  dual antiplatelet  therapy  (aspirin  and  clopido-
grel)  was  initiated,  and  then  cilostazol  was  added  on the following  day. Carotid  ultrasonography  and
three-dimensional  computed  tomographic  angiography  at 14  days  revealed  no further  obstruction  to
ﬂow.
DISCUSSION:  When  trying  to perform  emergency  carotid  artery  stenting  within  24  h  after  intravenous
recombinant  tissue  plasminogen  activator  administration,  several  issues  require  attention,  such as  the
decisions  regarding  the type  of  stent  and  embolic  protection  device,  the  selection  of  antiplatelet  therapy
and  the  methods  of preventing  hyperperfusion  syndrome.
CONCLUSION:  Emergency  carotid  artery  stenting  for the  acute  internal  carotid  artery  occlusion  may  be
considered  a safe  procedure  in preventing  early  stroke  recurrence  in  selected  patients.
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1. Introduction
Generally, in patients with acute ischemic strokes, intravenous
(IV) thrombolysis with recombinant tissue plasminogen activator
(rt-PA) is employed to recanalize thrombosed intracranial vessels
(such as the internal carotid artery (ICA) and the middle cere-
bral artery (MCA) and its branches) within 4.5 h [1–3]. In addition,
various reports have been published that a combination of IV
thrombolysis and early carotid revascularization via endovascular
technique might be a more effective secondary stroke prevention
strategy. On the other hand, during the ﬁrst 24 h after IV rt-PA
administration, the risk of intracranial hemorrhage associated with
early reperfusion might be increased because of hyperperfusion
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Magnetic resonance imaging (MRI) and MR angiography (MRA) ﬁndings. (A, B) MRI/diffusion-weighted imaging (DWI) at the time of initial presentation shows no
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dcute  cerebral infarction, but MRA  reveals complete occlusion of the right internal
ctivator (rt-PA), cervical MRA  demonstrates that the right ICA is still occluded.
yndrome (HPS) and the use of anticoagulant drugs or antiplatelet
gents [3–7]. Here, we present a case of acute ICA occlusion treated
uccessfully by use of the Penumbra System® and carotid artery
tenting (CAS) within 24 h after IV thrombolysis using rt-PA.
. Case report
A 68-year-old man  with a history of hypertension, hyper-
ipidemia and diabetes mellitus was admitted to our hospital.
eurological examination on admission revealed disturbance of
onsciousness and severe left-sided motor weakness (16 on the
ational Institutes of Health Stroke Scale). Blood biochemistry ﬁnd-
ngs revealed no evidence of inﬂammation or coagulation system
bnormalities. Electrocardiography indicated a sinus rhythm at 70
eats/min. Diffusion-weighted magnetic resonance imaging (MRI)
howed no acute cerebral infarction (Fig. 1A), but magnetic res-
nance angiography (MRA) revealed occlusion of the right ICA
Fig. 1B). We  made a diagnosis of acute cerebral ischemia, then
 systemic IV injection of rt-PA was performed 4 h after onset.
owever, neurological symptoms did not improve for 1 h. In addi-
ion, repeated MRA  (Fig. 1C) and cerebral angiography still revealed
omplete occlusion of the right cervical ICA at its origin (Fig. 2A). As
ollateral blood ﬂow from the contralateral anterior and posterior
irculation was poor, revascularization of the right cervical ICA was
erformed using an endovascular technique.
We performed all procedures under local anesthesia. An
PTIMO balloon-tipped guiding catheter (Tokai Medical Prod-
cts, Kasugai, Japan) was inserted into the right femoral artery
nd advanced until the tip reached the right common carotid
rtery (CCA). After blockage of the proximal blood ﬂow in the
ight CCA, an Excelsior SL-10® Microcatheter (Stryker Neurovas-
ular, Fremont, CA, USA) was inserted to the right ICA segment
istal to the occlusion area. Imaging study performed from theid artery (ICA). (C) After intravenous injection of recombinant tissue plasminogen
Excelsior SL-10® Microcatheter demonstrated obvious ﬂoating clot
in the cervical right ICA (Fig. 2B and C). Transluminal balloon
angioplasty was  performed with a 3.0-mm Gateway® MonorailTM
percutaneous transluminal angioplasty (PTA) Balloon Catheter
(Stryker Neurovascular) for the occluded area within the ICA
(Fig. 3A) and a Penumbra aspiration catheter 5MAXTM ACE (Penum-
bra, Alameda, CA, USA) was passed distal to the position. Then,
we performed a direct aspiration of the ﬂoating clot using this
Penumbra aspiration catheter (Fig. 3B). After recanalization of
the right ICA, a GuardWire® Temporary Occlusion & Aspiration
System (Medtronic, Minneapolis, MN,  USA) was passed through
the stenotic portion into the distal right ICA. Transluminal bal-
loon angioplasty was performed with a 3.5-mm Sterling PTA
balloon catheter (Boston Scientiﬁc, Natick, MA,  USA). Next, a
10 × 24-mm Carotid Wallstent Monorail® (Boston Scientiﬁc) was
deployed (Fig. 3C), and post-dilatation was performed using a 4.5-
mm Sterling PTA balloon catheter (Boston Scientiﬁc). Subsequent
angiography conﬁrmed successful recanalization of the right ICA
(thrombolysis in cerebral infarction (TICI) grade 3) at 7 h post-onset
(Fig. 3D).
Immediately after these procedures, we  started treatment with
dual-agent antiplatelet therapy (aspirin 100 mg/day and clopi-
dogrel 75 mg/day) and cilostazol 200 mg/day was  added on the
following day. The patient was  restless with neurological abnor-
malities, and 123I IMP-single photon emission tomography (SPECT)
(Fig. 4A) and INVOS-3100 revealed hyperperfusion in the territory
of the right ICA. Strict control of blood pressure under dexmedeto-
midine anesthesia allowed effective prevention of HPS. Carotid
ultrasonography and three-dimensional computed tomographic
angiography at 14 days (Fig. 4B and C) revealed no further obstruc-
tion to ﬂow, and the patient was discharged 3 weeks after surgery
with mild left motor weakness.
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Fig. 2. (A) Preoperative right common carotid angiography (CAG) revealing complete occlusion of the right internal carotid artery (ICA) at the origin; (B, C) Right internal
carotid angiography (ICAG) from Excelsior SL-10® demonstrating obvious ﬂoating clot (white arrow) in the cervical ICA (B: anteroposterior view; C: lateral view).
Fig. 3. Intraoperative angiography; (A) OPTIMO (black arrow) is placed at the right common carotid artery (CCA). Balloons placed in the CCA are inﬂated; then a transluminal
balloon angioplasty was  performed with a 3.0-mm GatewayTM PTA balloon catheter (white arrowhead) for the occluded area of the internal carotid artery (ICA). (B) Penumbra
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 carotid wall stent was  deployed and revascularization was  recognized. (D) Posto
n  cerebral infarction (TICI) grade 3).
. Discussion
In patients with acute cerebral infarction due to severe steno-
is or occlusion of the ICA, IV rt-PA alone has been reported to
e less effective, and its morbidity and mortality are higher than
onventional therapy [8,9]. In addition, acute ischemic stroke asso-
iated with cervical carotid occlusion at the origin is relatively rare,
o its management has not been studied extensively, and ther-
peutic approaches, in particular how to choose of antiplatelet
gents within 24 h after IV rt-PA, remain unclear. A combination
f IV thrombolysis using rt-PA and early carotid revascularizationwing suctioning of the ﬂoating clot (white arrow) using this aspiration system. (C)
ve angiography conﬁrmed successful recanalization of the right ICA (thrombolysis
by endovascular surgery might result in more effective secondary
stroke prevention. Several publications and studies have proposed
that recanalization via aggressive endovascular treatment of acute
cervical ICA occlusion at the origin may  be successful with high
rates of favorable outcomes [7,10]. However, at least in the ﬁrst
24 h after IV rt-PA administration, the risk of intracranial hemor-
rhage associated with early reperfusion of ischemic brain tissue
might be increased [11,12].
When trying to perform emergency CAS within 24 h after IV
rt-PA administration, several issues require attention, such as the
decisions regarding the type of stent and embolic protection device
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1  day after endovascular surgery) reveals increased cerebral blood ﬂow in the right
atency  14 days postoperatively.
EPD), the selection of antiplatelet therapy and the methods of pre-
enting HPS. At ﬁrst, with respect to emergency CAS, the selection
f type of stent and EPD is very important [3,6]. In the present
ase, although we were unable to evaluate the nature of the carotid
laques because of the need for emergency treatment, we  strongly
uspected that the plaque was vulnerable because of the sud-
en onset of symptoms. Because an open-cell stent often elicits
mbolic complications due to plaque protrusion, we selected a
elf-expandable closed-cell stent, and we were careful to avoid
ver-dilating the lesion. In addition, we also blocked the blood
ow in the proximal CCA only when doing PTA and advancing the
alloon-design EPD through the stenotic lesion to prevent scatter-
ng of the carotid plaque.
The second important point is the choice of perioperative
ntiplatelet agents. Antithrombotic therapy becomes required after
he CAS enforcement. Generally, the double antiplatelet regimen
s highly recommended before and after CAS in order to prevent
ubacute stent occlusion [3,6]. However, it is a generally accepted
rinciple that the administration of any anticoagulant drugs within
4 h after IV rt-PA therapy is contraindicated because of the risk of
leeding complications [2]. Furthermore, in the case of an emer-
ency CAS procedure, the administration of several antiplatelet
gents is particularly dangerous from the perspective of HPS
11–14]. On the other hand, Fabrizio et al. and Inoue et al. demon-
trated dual antiplatelet therapy, for example, the combination of
spirin (100 mg/day) and clopidogrel (75 mg/day) begun during the
mergency CAS procedure within 24 h after IV rt-PA therapy over
he 6 weeks after stent placement, resulting in good outcomes with-
ut serious hemorrhagic complications [15,16]. Therefore, in oured tomographic angiography (3D-CTA) and carotid ultrasonography. (A) PAO-SPECT
ral hemisphere. (B, C) 3D-CTA (B) and carotid ultrasonography (C) shows sufﬁcient
case, we administered aspirin and clopidogrel in the doses men-
tioned above for the prevention of subacute thrombosis, and we
also obtained a good result.
Finally, the risk of intracranial hemorrhage due to hyperper-
fusion is potentially high in patients with acute stroke receiving
emergency CAS because anticoagulation and antiplatelet medica-
tions must be administered during or after the procedure [16,17].
However, the development of HPS may be avoided by strict blood
pressure control [16–18]. Dexmedetomidine is a central alpha2
adrenoceptor agonist. Recently, this drug was shown to be a safe
and acceptable sedative agent for patients requiring sedation after
brain surgery including preventing hyperperfusion syndrome after
carotid endarterectomy [16,18]. In fact, although anticoagulation
and antiplatelet therapy were added immediately after the CAS
procedure in our case, careful control of blood pressure under
dexmedetomidine anesthesia enabled effective management of the
resulting HPS and there was  no intracranial hemorrhage.
This present case suggests that early treatment with CAS for
acute ischemic stroke due to ICA occlusion at the origin may
be considered a safe and feasible alternative modality to carotid
endarterectomy in selected patients at high risk of stroke recur-
rence, even if within 24 h after IV rt-PA administration.
4. ConclusionWe have described a case of cervical ICA occlusion treated suc-
cessfully with the Penumbra System® and emergency CAS within
24 h after injection of rt-PA thrombolysis. If we can make the appro-
priate perioperative management, emergency CAS for the acute
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CA occlusion at the origin may  be considered a safe procedure in
reventing early stroke recurrence in selected patients.
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